Clear Choice to treat infection caused by MRSA
CLEAR CHOICE TO TREAT INFECTIONS CAUSED BY MRSA
OFFERS A FAVORABLE SAFETY PROFILE IN A BROAD RANGE OF PATIENTS
Exhibits good activity against Staphylococci including strains resistant to Methicillin Glycopeptides & other antibacterial agents. Highly active against penicillin resistant S. Pneumonaei, Vancomycin-resistant E.Faecalis, Corynebacterium Sp, Moraxella Catarrhalis and Bacteroides Fragilis. Excellent option with significant resistant gram positive bacteremic infections. Safe and efficacious for Nosocomial Pneumonia.
DOSAGE & ADMINISTRATION:
Adults : 1 Tab (400 mg / 600 mg) twice a day for 10-14 days.
Children <12 Years : 20 mg – 30 mg / kg body weight in 2 divided doses in a day for 10-14 days.
MRP Rs. 1600